The Journal of Organic Chemistry
Page 8 of 13
The title compound was synthesized according to the general
Ethyl
(2S,2'S,6'S)-2'-(4-bromophenyl)-3,4'-dioxo-3H-
1
2
3
4
5
6
7
8
procedure GP5 (reaction time: 36 hours), affording the product as
a 9.6/1.9/1 diastereomeric mixture, with a yield of 39 mg (92%).
The major diastereomer, a yellow wax, was separated with a yield
of 22 mg (52%) and 92% ee (IA column, n-heptane:i-PrOH =
80:20; tR = 14.5 (minor.), 16.5 (major.) min), [α]D = -19.0°
(c 0.53; CHCl3). 1H NMR (400 MHz, CDCl3) δ 8.08 (s, 1H), 7.94
(dd, J = 8.2, 1.3 Hz, 1H), 7.62 (d, J = 8.8 Hz, 1H), 7.54 (d, J = 7.8
Hz, 1H), 7.40 (t, J = 7.6 Hz, 1H), 7.29 (t, J = 7.9 Hz, 1H), 7.14 (d,
J = 8.1 Hz, 1H), 7.09 (t, J = 7.5 Hz, 1H), 4.36 (dd, J = 12.7, 4.6
Hz, 1H), 4.23 – 4.10 (m, 2H), 3.70 – 3.60 (m, 2H), 3.54 – 3.51
(m, 1H), 2.72 (ddd, J = 15.8, 5.1, 1.7 Hz, 1H), 2.65 (ddd, J = 15.2,
4.6, 1.7 Hz, 1H), 1.16 (t, J = 7.1 Hz, 3H) ppm. 13C{1H} NMR
(101 MHz, CDCl3) δ 206.1, 201.6, 171.5, 150.6, 147.4, 138.9,
136.3, 135.2, 130.7, 128.7, 126.8, 125.3, 124.4, 123.5, 122.8,
64.1, 61.9, 47.7, 47.1, 42.4, 39.4, 13.8 ppm. IR (KBr): ν = 3076,
2983, 2935, 1724, 1679, 1586, 1527, 1449, 1347, 1308, 1278,
1222, 1189, 1147, 1099, 1018, 905, 806, 746 cm-1. HRMS (ESI)
m/z: [M+Na]+ calcd for C22H19O6NNaS+ 448.0826; found
448.0825.
spiro[benzo[b]thiophene-2,1'-cyclohexane]-6'-carboxylate
(3ag)
The title compound was synthesized according to the general
procedure GP5 (reaction time: 36 hours), affording the product as
a 13.8/1.9/1 diastereomeric mixture, with a yield of 44 mg (96%).
The major diastereomer, a yellowish wax, was separated with a
yield of 29 mg (62%) and 93% ee (IB column, n-heptane:i-PrOH
= 80:20; tR = 9.4 (major.), 10.8 (minor.) min), [α]D = -32.2°
1
(c 0.45; CHCl3). H NMR (600 MHz, CDCl3) δ 7.61 (d, J = 7.7
Hz, 1H), 7.45 – 7.42 (m, 1H), 7.23 (d, J = 8.5 Hz, 2H), 7.18 (d, J
= 8.0 Hz, 1H), 7.12 (t, J = 7.5 Hz, 1H), 7.04 (d, J = 8.5 Hz, 2H),
4.15 – 4.08 (m, 3H), 3.57 – 3.50 (m, 3H), 2.72 – 2.67 (m, 1H),
2.63 (ddd, J = 15.4, 4.6, 1.3 Hz, 1H), 1.09 (t, J = 7.1 Hz, 3H)
ppm. 13C{1H} NMR (151 MHz, CDCl3) δ 206.9, 201.7, 171.3,
150.7, 136.1, 135.9, 130.9 (2C+2C overlapped), 130.7, 126.7,
125.1, 123.5, 121.7, 64.6, 61.7, 47.5, 47.1, 43.0, 39.3, 13.8 ppm.
IR (KBr): ν = 3067, 2989, 2905, 1727, 1673, 1583, 1485, 1446,
1332, 1281, 1216, 1186, 1150, 1009, 869, 824 cm-1. HRMS (ESI)
m/z: [M+Na]+ calcd for C22H19O4BrNaS+ 481.0080; found
481.0081.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Ethyl
(2S,2'S,6'S)-6'-(2-nitrophenyl)-3,4'-dioxo-3H-
spiro[benzo[b]thiophene-2,1'-cyclohexane]-2'-carboxylate
(3ae)
Ethyl
(2S,2'S,6'S)-3,4'-dioxo-6'-(p-tolyl)-3H-
spiro[benzo[b]thiophene-2,1'-cyclohexane]-2'-carboxylate
(3ah)
The title compound was synthesized according to the general
procedure GP5 (reaction time: 36 hours), affording the product as
a 26.5/7.4/1 diastereomeric mixture, with a yield of 41 mg (96%).
The major diastereomer, yellowish wax, was separated with a
yield of 20 mg (47%) and 86% ee (IA column, n-heptane:i-PrOH
= 80:20; tR = 15.9 (minor.), 19.5 (major.) min), [α]D = +141.4°
(c 0.49; CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.72 (dd, J = 8.1,
1.5 Hz, 1H), 7.64 – 7.62 (m, 1H), 7.47 – 7.43 (m, 1H), 7.39 – 7.35
(m, 1H), 7.31 – 7.25 (m, 2H), 7.21 (d, J = 7.9 Hz, 1H), 7.16 –
7.12 (m, 1H), 5.17 (dd, J = 10.3, 5.2 Hz, 1H), 4.16 – 4.08 (m,
2H), 3.55 – 3.43 (m, 3H), 2.84 – 2.74 (m, 2H), 1.10 (t, J = 7.1 Hz,
3H) ppm. 13C{1H} NMR (101 MHz, CDCl3) δ 206.2, 201.6,
170.5, 150.7, 150.3, 136.1, 132.2, 131.9, 130.8, 129.4, 128.5,
126.7, 125.3, 124.7, 123.7, 64.5, 62.0, 47.4, 42.7, 40.8, 39.7, 13.7
ppm. IR (KBr): ν = 3085, 2989, 2926, 1718, 1679, 1583, 1530,
1446, 1353, 1278, 1222, 1180, 1156, 1138, 1015, 851, 756 cm-1.
HRMS (ESI) m/z: [M+Na]+ calcd for C22H19O6NNaS+ 448.0825;
found 448.0825.
The title compound was synthesized according to the general
procedure GP5 (reaction time: 36 hours), affording the product as
a 12.7/1.2/1 diastereomeric mixture, with a yield of 38 mg (95%).
The major diastereomer, an off-white wax, was separated with a
yield of 30 mg (75%) and 96% ee (IC column, n-heptane:i-PrOH
= 80:20; tR = 18.1 (minor.), 22.0 (major.) min), [α]D = -34.0°
1
(c 0.53; CHCl3). H NMR (400 MHz, CDCl3) δ 7.63 (d, J = 9.2
Hz, 1H), 7.44 – 7.41 (m, 1H), 7.20 (d, J = 8.1 Hz, 1H), 7.13 –
7.09 (m, 1H), 7.01 (d, J = 8.2 Hz, 2H), 6.93 (d, J = 7.7 Hz, 2H),
4.15 – 4.05 (m, 2H), 4.01 (dd, J = 11.4, 5.2 Hz, 1H), 3.62 – 3.58
(m, 1H), 3.54 – 3.45 (m, 2H), 2.75 – 2.68 (m, 2H), 2.19 (s, 3H),
1.07 (t, J = 7.1 Hz, 3H) ppm. 13C{1H} NMR (101 MHz, CDCl3) δ
207.6, 201.7, 171.2, 150.7, 137.3, 135.7, 134.0, 130.9, 129.1 (2C),
128.6 (2C), 126.7, 124.9, 123.5, 65.2, 61.5, 47.8, 47.2, 43.6, 39.6,
20.9, 13.7 ppm. IR (KBr): ν = 3058, 2980, 2929, 1718, 1679,
1586, 1512, 1449, 1308, 1281, 1216, 1189, 1150, 1060, 1024,
869, 737 cm-1. HRMS (ESI) m/z: [M+Na]+ calcd for
C23H22O4NaS+ 417.1131; found 417.1132.
Ethyl (2S,2'S,6'S)-3,4'-dioxo-6'-(4-(trifluoromethyl)phenyl)-
3H-spiro[benzo[b]thiophene-2,1'-cyclohexane]-2'-carboxylate
(3af)
Ethyl
(2R,2'S,6'S)-3,4'-dioxo-6'-(thiophen-2-yl)-3H-
spiro[benzo[b]thiophene-2,1'-cyclohexane]-2'-carboxylate
(3ai)
The title compound was synthesized according to the general
procedure GP5 (reaction time: 36 hours), affording the product as
a 10.1/2.1/1 diastereomeric mixture, with a yield of 43 mg (95%).
The major diastereomer, a white foam, was separated with a yield
of 28 mg (63%) and 90% ee (IA column, n-heptane:i-PrOH =
90:10; tR = 14.8 (major.), 17.5 (minor.) min), [α]D = -27.5°
The title compound was synthesized according to the general
procedure GP5 (reaction time: 36 hours), affording the product as
a 9.6/1.3/1 diastereomeric mixture, with a yield of 36 mg (93%).
The major diastereomer, a yellow wax, was separated with a yield
of 27 mg (69%) and 95% ee (IC column, n-heptane:i-PrOH =
80:20; tR = 18.5 (minor.), 21.4 (major.) min), [α]D = -20.8°
(c 0.51; CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.64 (dd, J = 7.8,
0.7 Hz, 1H), 7.49 – 7.45 (m, 1H), 7.27 – 7.25 (m, 1H), 7.14 (t, J =
7.5 Hz, 1H), 7.02 (dd, J = 5.1, 1.2 Hz, 1H), 6.85 – 6.84 (m, 1H),
6.77 (dd, J = 5.1, 3.5 Hz, 1H), 4.43 (dd, J = 11.5, 4.9 Hz, 1H),
4.18 – 4.06 (m, 2H), 3.60 – 3.47 (m, 3H), 2.81 (ddd, J = 15.3, 4.9,
1.5 Hz, 1H), 2.68 (ddd, J = 15.8, 6.1, 1.5 Hz, 1H), 1.11 (t, J = 7.1
Hz, 3H) ppm. 13C{1H} NMR (101 MHz, CDCl3) δ 206.3, 201.5,
171.3, 150.9, 139.8, 135.9, 130.7, 126.9, 126.9, 126.2, 125.1,
124.7, 123.6, 64.7, 61.7, 47.6, 44.7, 43.4, 39.3, 13.8 ppm. IR
(KBr): ν = 3064, 2980, 2929, 1721, 1682, 1583, 1446, 1371,
1332, 1284, 1192, 1120, 1063, 1021, 878, 740 cm-1. HRMS (ESI)
1
(c 0.46; CHCl3). H NMR (400 MHz, CDCl3) δ 7.61 (d, J = 7.8
Hz, 1H), 7.45 – 7.41 (m, 1H), 7.37 (d, J = 8.2 Hz, 2H), 7.29 (d, J
= 8.3 Hz, 2H), 7.17 (d, J = 7.9 Hz, 1H), 7.11 (t, J = 7.5 Hz, 1H),
4.23 (dd, J = 12.2, 4.6 Hz, 1H), 4.20 – 4.07 (m, 2H), 3.64 – 3.53
(m, 3H), 2.75 – 2.69 (m, 1H), 2.66 (dd, J = 15.3, 4.6 Hz, 1H),
1.12 (t, J = 7.1 Hz, 3H) ppm. 13C{1H} NMR (101 MHz, CDCl3) δ
206.6, 201.6, 171.4, 150.6, 141.0, 136.1, 130.7, 129.9 (q, J = 32.3
Hz, 1C), 129.7 (2C), 126.8, 125.2, 124.7 (q, J = 3.8 Hz, 2C),
123.8 (q, J = 272.7 Hz, 1C), 123.6, 64.5, 61.7, 47.6, 47.5, 42.8,
39.4, 13.8 ppm. 19F NMR (376 MHz, CDCl3) δ -62.75 (s, 3F)
ppm. IR (KBr): ν = 3064, 2956, 2920, 1730, 1682, 1586, 1452,
1419, 1329, 1281, 1171, 1126, 1069, 1018, 833, 767 cm-1. HRMS
(ESI) m/z: [M+Na]+ calcd for C23H19O4F3NaS+ 471.0844; found
471.0848.
+
m/z: [M+Na]+ calcd for C20H18O4NaS2 409.0539; found
409.0541.
ACS Paragon Plus Environment